Yuhan Corp. will hold its annual shareholders' meeting next month and decide whether to reappoint Cho Wook-je as its president and CEO. Industry officials watch with interest whether Cho will serve another term.The company issued a public notice last Tuesday, announcing that it would hold its annual
Celltrion said it has completed its application for marketing authorization to the European Medicines Agency (EMA) for CT-P47, a biosimilar referencing Actemra.Roche's Actemra (ingredient: tocilizumab), known as RoActemra in Europe, is approved for a wide range of conditions, including rheumatoid ar
A new treatment has landed in Korea for moderate to severe active ulcerative colitis that has not responded adequately to standard treatments or biologics or has become unresponsive.Lilly Korea said Thursday that the interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab) has received approval from the
Severance Hospital has succeeded in conducting Korea's first irreversible electroporation surgery technique on a 76-year-old liver cancer patient. The patient has since been discharged and is now resuming normal daily activities.IRE involves creating small gaps of about 2mm in the cancerous tissue b
Eutilex said Thursday that it has completed registering a patent for antibody therapy, “103,” in China.The patent for “103” was registered as "Anti-Human VSIG4 Antibody and Uses Thereof." Eutilex, which has completed patient registration in the U.S. and Russia, expects to expand its business territo
C-Biomex said Thursday that it has entered into a collaborative research agreement with MD Anderson Cancer Center to proceed with the U.S. investigational new drug (IND) application for its radiopharmaceutical therapy, CBT-001.CBT-001 targets CA-9 (Carbonic anhydrase 9), which is overexpressed in ki
OCI Holdings Chairman Lee Woo-hyun has reaffirmed the company's strategy to play a minimal role in the management of Hanmi Group following the upcoming integration with Hanmi Science.During an investor conference call on Wednesday, Chairman Lee stated that OCI Holdings intends to support Hanmi Group
JW Pharmaceutical has posted record earnings in 2023, driven by increased sales of its hyperlipidemia drugs Livalo (pitavastatin) and LivaloZet and hemophilia drug Hemlibra.JW Pharmaceutical released its preliminary operating results for the past year through a disclosure of changes in sales or prof
Seoul National University Bundang Hospital (SNUBH) said on Thursday that Professor Kim Yeon-wook of the Pulmonology Department has been appointed as a member of the multidisciplinary practice standards committee of the International Association for the Study of Lung Cancer (IASLC). Kim's tenure in t
Yongin Severance Hospital has started prescribing Somzz, the first digital therapeutics (DTx) device in Korea, for older adults with insomnia.Somzz, approved by the Ministry of Food and Drug Safety in February last year, implements cognitive behavioral therapy, the optimum standard treatment for ins
GC Biopharma recorded disappointing results last year due to a decline in Covid-19-related demand and the slowing exports of Hunterase amid rising geopolitical risks.GC Biopharma released its preliminary consolidated operating results for 2023 by disclosing changes in sales or profit and loss struct
Yuhan Corp. said it posted highest-ever annual sales in 2023 thanks to technology export revenue.The company reported consolidated sales and operating profit of 1.8 trillion won ($1.3 billion) and 56.7 billion won in 2023, up 4.7 percent and 57.6 percent year-on-year. Net profit also jumped 57.4 per
The Seoul High Court on Wednesday upheld the lower court's decision, rejecting Kolon Life Science's appeal to suspend the Ministry of Food and Drug Safety's order cancelling the approval for Invossa-K, a gene therapy for osteoarthritis.This decision marks the second defeat for Kolon Life Science in
Researchers at Seoul National University Bundang Hospital (SNUBH) have successfully developed and demonstrated a groundbreaking technology that expedites skin wound healing devoid of antibiotics, leveraging metal-organic frameworks (MOFs).Antibiotics have undeniably been instrumental in prolonging h
With the establishment of a new medical device category for lubricating gels, regulators are now outlining test methods to guide its evaluation.The Ministry of Food and Drug Safety (MFDS) said Wednesday that it has published and distributed the “Information Sheet on Test Methods for Personal Lubrica
Prestige Biopharma said Wednesday that the dosing of its Avastin biosimilar, HD204, conducted by global contract research organization (CRO) IQVIA, will be completed this month.HD204 is being studied in a global phase 3 clinical trial by two leading CROs, enrolling 650 patients in 17 countries world
VUNO, a Korean medical AI company, said Wednesday that its research on a self-supervised learning (SSL) algorithm to improve the efficiency and accuracy of artificial intelligence-based ECG data analysis has been adopted by the International Conference on Learning Representations (ICLR).ICLR, now in
Bayer Korea said it has entered into a strategic partnership with Chong Kun Dang to co-market Kerendia (ingredienet: finerenone), Bayer's novel treatment for chronic kidney disease (CKD) in patients with type 2 diabetes.Kerendia received approval from the Ministry of Food and Drug Safety in May 2022
Precision medicine is changing the treatment performance of many adult cancers, including lung, colon, and breast cancer. By identifying the "driver gene mutations" that cause cancer and targeting them with therapies, the cure rate is increasing. What about pediatric cancers, however?It is widely un
The Ministry of Food and Drug Safety (MFDS) plans to strengthen the control of medical narcotics by making the most of the risk management plan (RMP).Drug Safety Planning Officer Chae Kyu-han said the ministry would shore up the management of medical narcotics through RMPs and provide more safety in